Trials / Completed
CompletedNCT02821169
Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain
Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.
Detailed description
A prospective randomized double blind placebo controlled study was designed. Local injection of ropivacaine or placebo was conducted at the end of the surgical procedure in both nasal fossa through endoscopic view in the sphenopalatine region. Pain was measured in the postoperative course with visual analogic scale in the recovery room and the rhinologic department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ropivacaine | injection of 4mL of ropivacaine in the sphenopalatine area through an endoscopic approach |
| DRUG | saline solution 0.9% | injection of 4 mL of saline solution in the sphenopalatine area through an endoscopic approach |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2019-06-01
- Completion
- 2019-06-01
- First posted
- 2016-07-01
- Last updated
- 2025-12-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02821169. Inclusion in this directory is not an endorsement.